the N and C termini (Weiss et al., 2000) . In addition,
Whereas all arginine methyltransferase activities identhough early purification of mammalian protein arginine tified to date can monomethylate arginine in the context methyltransferases used methylation of histones to of a protein substrate, methyltransferases have been track activity, the majority of nuclear asymmetric diclassified as type I or type II enzymes according to methylarginine residues are found in heterogeneous nuwhether further dimethylation is asymmetric (type I) or clear ribonucleoproteins (hnRNPs), which play roles in symmetric (type II). Most PRMT genes discovered to pre-mRNA processing and nucleocytoplasmic RNA date encode type I enzymes, but recent data have retransport. Subsequent work on numerous hnRNPs and vealed that PRMT5/JBP1 (Janus kinase binding protein other RNA binding proteins has revealed that they are 1) is a type II methyltransferase (Branscombe et al., methylated on arginine residues, frequently in the con-2001). Although in vivo substrates for the type I PRMT1/ text of RGG tripeptides. Notably, all methylarginine resiHmt1 enzymes have been defined, the substrate specidues within RGG motifs have been shown to be MMA ficity of the majority of arginine methyltransferases reor aDMA rather than sDMA. Proteins have also been mains mysterious. In the case of PRMT3, however, its identified that are asymmetrically dimethylated at RXR N-terminal zinc finger domain has been shown to influand RG motifs. ence its substrate specificity . Myelin basic protein, which was one of the first argiThe three-dimensional structures of the core regions nine-methylated proteins identified, stands in contrast of yeast Hmt1 and human PRMT3 have been determined to most methylated RNA binding proteins in that it conby X-ray crystallography and a comparison of these tains symmetrically dimethylated arginine residues in structures underscores the structural similarity between addition to monomethylarginine. Recently, however, these enzymes ( Figure 2B) 
